{"id":"NCT00252733","sponsor":"AstraZeneca","briefTitle":"Diabetic Retinopathy Candesartan Trials","officialTitle":"Effects of Candesartan Cilexetil (Candesartan) on Diabetic Retinopathy in Type 1 Diabetic Patients Without Retinopathy.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2001-06","primaryCompletion":"2008-04","completion":"2008-04","firstPosted":"2005-11-15","resultsPosted":"2012-04-13","lastUpdate":"2014-05-14"},"enrollment":5238,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 1 Diabetes"],"interventions":[{"type":"DRUG","name":"candesartan cilexetil","otherNames":["ATACAND"]}],"arms":[{"label":"1","type":"NO_INTERVENTION"},{"label":"2","type":"EXPERIMENTAL"}],"summary":"The primary objective is to determine whether candesartan, compared to placebo reduces the incidence of diabetic retinopathy in normotensive, normoalbuminuric type 1 diabetic patients without retinopathy.\n\nThe secondary objective is to determine whether candesartan, compared to placebo, beneficially influences the rate of change in urinary albumin excretion rate (UAER).\n\nThis study is part of the DIRECT Programme also including secondary prevention studies of diabetic retinopathy in both type 1 and type 2 diabetes. The primary objective for all three pooled studies is to determine whether candesartan, compared to placebo, reduces the incidence of microalbuminuria in type 1 and type 2 diabetic patients.","primaryOutcome":{"measure":"Number of Participants With a 2-step or Greater Increase in Early Treatment Diabetic Retinopathy Study (ETDRS) Severity Scale.","timeFrame":"From baseline to end of study, i.e. 5 years, with visits after a half year, one year and thereafter one visit per year.","effectByArm":[{"arm":"Candesartan","deltaMin":178,"sd":0.071},{"arm":"Placebo","deltaMin":217,"sd":0.086}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0508"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":14},"locations":{"siteCount":3,"countries":["Australia","Denmark"]},"refs":{"pmids":["38682786","21309844","21225239","19451554","18823656"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=308&filename=CSR-D2453C00045.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=308&filename=CSR-D2453C00045.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":102,"n":710},"commonTop":["Hypotension"]}}